Serotonin signals through a gut-liver axis to regulate hepatic steatosis

Nonalcoholic fatty liver disease (NAFLD) is increasing in worldwide prevalence, closely tracking the obesity epidemic, but specific pharmaceutical treatments for NAFLD are lacking. Defining the key molecular pathways underlying the pathogenesis of NAFLD is essential for developing new drugs. Here we...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Wonsuk, Namkung, Jun, Hwang, Inseon, Kim, Hyeongseok, Lim, Ajin, Park, Hye Jung, Lee, Hye Won, Han, Kwang-Hyub, Park, Seongyeol, Jeong, Ji-Seon, Bang, Geul, Kim, Young Hwan, Yadav, Vijay K., Karsenty, Gerard, Ju, Young Seok, Choi, Chan, Suh, Jae Myoung, Park, Jun Yong, Park, Sangkyu, Kim, Hail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240035/
https://www.ncbi.nlm.nih.gov/pubmed/30446669
http://dx.doi.org/10.1038/s41467-018-07287-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240035/
https://www.ncbi.nlm.nih.gov/pubmed/30446669
http://dx.doi.org/10.1038/s41467-018-07287-7

Ejemplares similares